Trill Impact is a venture capital fund focusing on Series B investments in Health Tech and Biotech. Managing assets worth approximately EUR 1.2 billion, the fund aims to create positive changes through its investments. With a team of about 50 professionals based in the Nordics, Germany, Luxembourg, and the USA, Trill Impact has backed companies like May Health. Their mission is to deliver real returns and lasting impact, benefiting investors, businesses, and society.
